Abstract: The present disclosure discloses a method for processing information of a base station and system, and related devices, and relates to the technical field of communication technology. The method of the present disclosure is executed by a network access control function (NACF), including: receiving base station status information sent from each of a plurality of base stations; determining a handover priority for the each of the plurality of base stations based on the base station status information of the each of the plurality of base stations; and sending to the each of the plurality of base stations the handover priority of a relevant base station of the each of the plurality of base stations.

Abstract: Techniques are provided for determining and updating locations in databases for providing to transport user devices to facilitate picking up (retrieving) an item and delivery. Location points (e.g., for retrieval or delivery) can be measured by transporter devices when an item is retrieved, and a central value can be determined from the measured location points. The central value can be used to update a pin location in a database for a destination, e.g., when more paths by the transport user devices cross a boundary (geofence) around then central value than a boundary around an existing pin location.

Abstract: This disclosure relates to combination therapies comprising anti-Pseudomonas Psl and PcrV binding molecules and related compositions, for use in prevention and treatment of Pseudomonas infection.

Abstract: A weakly coupled enhanced graphene film includes an enhanced graphene structure based on weak coupling, wherein the enhanced graphene structure based on weak coupling comprises a plurality of graphene units stacked vertically; the graphene unit is a single graphene sheet, or consists of two or more graphene sheets stacked in AB form; two vertically adjacent graphene units are weakly coupled, to promote the hot electron transition and increase the joint density of states, thereby increasing the number of hot electrons in high-energy states; the stacking direction of the graphene units in the graphene structure is in the thickness direction of the graphene film; and the graphene film enhances the accumulation of hot electrons in high-energy states by the enhanced graphene structure based on weak coupling.

Abstract: Techniques are provided for determining and updating locations in databases for providing to transport user devices to facilitate picking up (retrieving) an item and delivery. Location points (e.g., for retrieval or delivery) can be measured by transporter devices when an item is retrieved, and a central value can be determined from the measured location points. The central value can be used to update a pin location in a database for a destination, e.g., when more paths by the transport user devices cross a boundary (geofence) around then central value than a boundary around an existing pin location.

Abstract: The disclosure relates to an antibody of the class IgG4 comprising two heavy chains, wherein each of the heavy chains comprises a human IgG4 constant region comprising a mutation. The disclosure further relates to methods of treating a disorder or condition using the IgG4 antibody comprising two heavy chains, wherein each of the heavy chains comprises a human IgG4 constant region comprising a mutation.

Abstract: A foldable LED display screen includes a first display screen, a second display screen, and a hinge. The hinge includes a first hinge block, a second hinge block, a first connecting piece, and a second connecting piece. The first hinge block embedded in the first connecting end without protruding from the first connecting end, the second hinge block embedded in the second connecting end without protruding from the second connecting end. One end of the first connecting piece is slidably connected to the first hinge block, and another end of the first connecting piece is hinged to the second hinge block. One end of the second connecting piece is slidably connected to the second hinge block, and another end of the second connecting piece is hinged to the first hinge block. The second connecting piece is hinged with the first connecting piece through the hinge shaft.

Abstract: A policy mapping module maintains and distributes policy maps indicating recommended security categories/category attributes for endpoint devices managed by a server device. Based on detecting a login event at an endpoint device, the policy mapping module communicates parameters of the updated policy map to the server device. The server device communicates the policy map to the endpoint device that deploys the policy map on a corresponding probing agent. The probing agent communicates reports of changes to categories/category attributes from the policy map to the server device, and the server device enforces its security policy based on evaluating the changes against security policies at the server device.

Abstract: This disclosure relates to combination therapies comprising anti-Pseudomonas Psl and PcrV binding molecules and related compositions, for use in prevention and treatment of Pseudomonas infection.

Abstract: The invention provides compositions and methods for treating a patient with cancer with an immune cell, e.g., a T-cell, e.g., an engineered T-cell, with increased sialidase activity. The invention also provides compositions and methods for treating a patient with cancer with an immune cell, e.g., a T-cell, e.g., an engineered T-cell, in combination with a sialidase. The invention also provides compositions and methods for treating a patient with cancer with an immune cell, e.g., a T-cell, e.g., an engineered T-cell, pretreated with a sialidase.

Abstract: A foldable LED display screen includes a first display screen, a second display screen, and a hinge. The hinge includes a first hinge block, a second hinge block, a first connecting piece, and a second connecting piece. The first hinge block embedded in the first connecting end without protruding from the first connecting end, the second hinge block embedded in the second connecting end without protruding from the second connecting end. One end of the first connecting piece is slidably connected to the first hinge block, and another end of the first connecting piece is hinged to the second hinge block. One end of the second connecting piece is slidably connected to the second hinge block, and another end of the second connecting piece is hinged to the first hinge block. The second connecting piece is hinged with the first connecting piece through the hinge shaft.

Abstract: Disclosed is a display screen device. The display screen device includes a lifting structure, a display screen, a main control unit, a driving unit, a power supply unit, and an anti-collision unit. The display screen is fixed to the lifting structure. The main control unit is electrically connected to the display screen. The driving unit is electrically connected to the main control unit and configured to drive the lifting structure. The power supply unit is configured to supply power to the display screen, the main control unit, and the driving unit. The anti-collision unit is provided in the lifting structure and electrically connected to the main control unit, and the anti-collision unit is configured to detect an impact happening to the lifting structure when the lifting structure is lifting or lowering.

Abstract: The invention relates generally to recombinant human sialidases and recombinant sialidase fusion proteins, wherein the sialidase optionally contains one or more mutations compared to wild-type human sialidase, e.g., a substitution, deletion, or addition of at least one amino acid. The invention also provides antibody conjugates including a sialidase and an antibody or a portion thereof. The invention further relates to methods of using the sialidase fusion proteins or antibody conjugates for treating cancer.

Abstract: The invention relates generally to proteins comprising a recombinant Siglec extracellular domain (ECD), or a functional fragment or variant thereof, optionally containing a mutation that reduces sialic acid binding activity and/or conjugated to a serum half-life enhancer. The invention further relates to methods of using the proteins for treating an inflammatory disorder and/or an autoimmune disorder.

Abstract: Systems, apparatuses, and methods for efficient parallel execution of multiple work units in a processor by reducing a number of memory accesses are disclosed. A computing system includes a processor core with a parallel data architecture. One or more of a software application and firmware implement matrix operations and support the broadcast of shared data to multiple compute units of the processor core. The application creates thread groups by matching compute kernels of the application with data items, and grouping the resulting work units into thread groups. The application assigns the thread groups to compute units based on detecting shared data among the compute units. Rather than send multiple read access to a memory subsystem for the shared data, a single access request is generated. The single access request includes information to identify the multiple compute units for receiving the shared data when broadcasted.

Abstract: The invention relates generally to recombinant human sialidases and recombinant sialidase fusion proteins, wherein the sialidase optionally contains one or more mutations compared to wild-type human sialidase, e.g., a substitution, deletion, or addition of at least one amino acid. The invention also provides antibody conjugates including a sialidase and an antibody or a portion thereof. The invention further relates to methods of using the sialidase fusion proteins or antibody conjugates for treating cancer.

Abstract: The invention relates generally to anti-PD-L1 antibodies, and recombinant sialidase and anti-PD-L1 immunoglobulin antigen-binding domain fusion proteins. The invention also provides antibody conjugates including a sialidase and an anti-PD-L1 antibody or a portion thereof. The invention further relates to methods of using the antibodies, sialidase fusion proteins, or antibody conjugates for treating cancer.

Abstract: The invention relates generally to recombinant sialidase and anti-HER2 immunoglobulin antigen-binding domain fusion proteins. The invention also provides antibody conjugates including a sialidase and an anti-HER2 antibody or a portion thereof. The invention further relates to methods of using the sialidase fusion proteins or antibody conjugates for treating cancer.

Abstract: The invention relates generally to recombinant sialidase and anti-PD-1 immunoglobulin antigen-binding domain fusion proteins. The invention also provides antibody conjugates including a sialidase and an anti-PD-1 antibody or a portion thereof. The invention further relates to methods of using the sialidase fusion proteins or antibody conjugates for treating cancer.